128 related articles for article (PubMed ID: 21231887)
1. Proteomic detection of cancer in asbestosis patients using SELDI-TOF discovered serum protein biomarkers.
Tooker BC; Newman LS; Bowler RP; Karjalainen A; Oksa P; Vainio H; Pukkala E; Brandt-Rauf PW
Biomarkers; 2011 Mar; 16(2):181-91. PubMed ID: 21231887
[TBL] [Abstract][Full Text] [Related]
2. Detection of serum protein biomarkers by surface enhanced laser desorption/ionization in patients with adenocarcinoma of the lung.
Jiang M; Gu G; Ni B; Wang W; Shi J; Liao P; Hu H
Asia Pac J Clin Oncol; 2014 Jun; 10(2):e7-12. PubMed ID: 23441957
[TBL] [Abstract][Full Text] [Related]
3. Importance of serum SELDI-TOF-MS analysis in the diagnosis of early lung cancer.
Simsek C; Sonmez O; Keyf AI; Yurdakul AS; Ozturk C; Gulbahar O; Ozmen F; Zengin N; Kubilay D; Karatayli SC; Bozdayi M
Asian Pac J Cancer Prev; 2013; 14(3):2037-42. PubMed ID: 23679315
[TBL] [Abstract][Full Text] [Related]
4. [Comparative study of protein markers in serum and bronchoalveolar lavage fluid from patients with lung cancer by surface-enhanced laser desorption ionization time of flight mass spectrometry].
Zhou JH; Liu GN; Huang SM; Zhong XN; Su H; Zhou Y
Zhonghua Jie He He Hu Xi Za Zhi; 2011 Apr; 34(4):274-7. PubMed ID: 21609611
[TBL] [Abstract][Full Text] [Related]
5. Identification of a 17-protein signature in the serum of lung cancer patients.
Sreseli RT; Binder H; Kuhn M; Digel W; Veelken H; Sienel W; Passlick B; Schumacher M; Martens UM; Zimmermann S
Oncol Rep; 2010 Jul; 24(1):263-70. PubMed ID: 20514471
[TBL] [Abstract][Full Text] [Related]
6. Detection and significance of serum protein markers of small-cell lung cancer.
Han M; Liu Q; Yu J; Zheng S
J Clin Lab Anal; 2008; 22(2):131-7. PubMed ID: 18348318
[TBL] [Abstract][Full Text] [Related]
7. [Serum proteomic patterns may assist the diagnosis of solitary pulmonary nodules].
Luo XY; Chen HQ; Sun YH; Zhou JH; Wang WF; Liao P; Xiang CQ
Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):907-10. PubMed ID: 17533741
[TBL] [Abstract][Full Text] [Related]
8. A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry.
Liu XP; Shen J; Li ZF; Yan L; Gu J
Cancer Invest; 2006 Dec; 24(8):747-53. PubMed ID: 17162557
[TBL] [Abstract][Full Text] [Related]
9. Differential capture of serum proteins for expression profiling and biomarker discovery in pre- and posttreatment head and neck cancer samples.
Freed GL; Cazares LH; Fichandler CE; Fuller TW; Sawyer CA; Stack BC; Schraff S; Semmes OJ; Wadsworth JT; Drake RR
Laryngoscope; 2008 Jan; 118(1):61-8. PubMed ID: 18043497
[TBL] [Abstract][Full Text] [Related]
10. SELDI-TOF MS combined with magnetic beads for detecting serum protein biomarkers and establishment of a boosting decision tree model for diagnosis of pancreatic cancer.
Qian JY; Mou SH; Liu CB
Asian Pac J Cancer Prev; 2012; 13(5):1911-5. PubMed ID: 22901146
[TBL] [Abstract][Full Text] [Related]
11. Detection of lung cancer using plasma protein profiling by matrix-assisted laser desorption/ionization mass spectrometry.
Shevchenko VE; Arnotskaya NE; Zaridze DG
Eur J Mass Spectrom (Chichester); 2010; 16(4):539-49. PubMed ID: 20625202
[TBL] [Abstract][Full Text] [Related]
12. Support vector machines coupled with proteomics approaches for detecting biomarkers predicting chemotherapy resistance in small cell lung cancer.
Han M; Dai J; Zhang Y; Lin Q; Jiang M; Xu X; Liu Q; Jia J
Oncol Rep; 2012 Dec; 28(6):2233-8. PubMed ID: 22992788
[TBL] [Abstract][Full Text] [Related]
13. New serum biomarkers for detection of endometriosis using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
Zheng N; Pan C; Liu W
J Int Med Res; 2011; 39(4):1184-92. PubMed ID: 21986120
[TBL] [Abstract][Full Text] [Related]
14. Identification of serum biomarkers for lung cancer using magnetic bead-based SELDI-TOF-MS.
Song QB; Hu WG; Wang P; Yao Y; Zeng HZ
Acta Pharmacol Sin; 2011 Dec; 32(12):1537-42. PubMed ID: 22019958
[TBL] [Abstract][Full Text] [Related]
15. Application of serum SELDI proteomic patterns in diagnosis of lung cancer.
Yang SY; Xiao XY; Zhang WG; Zhang LJ; Zhang W; Zhou B; Chen G; He DC
BMC Cancer; 2005 Jul; 5():83. PubMed ID: 16029516
[TBL] [Abstract][Full Text] [Related]
16. Development of proteomic patterns for detecting lung cancer.
Xiao X; Liu D; Tang Y; Guo F; Xia L; Liu J; He D
Dis Markers; 2003-2004; 19(1):33-9. PubMed ID: 14757945
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic accuracy of MALDI mass spectrometric analysis of unfractionated serum in lung cancer.
Yildiz PB; Shyr Y; Rahman JS; Wardwell NR; Zimmerman LJ; Shakhtour B; Gray WH; Chen S; Li M; Roder H; Liebler DC; Bigbee WL; Siegfried JM; Weissfeld JL; Gonzalez AL; Ninan M; Johnson DH; Carbone DP; Caprioli RM; Massion PP
J Thorac Oncol; 2007 Oct; 2(10):893-901. PubMed ID: 17909350
[TBL] [Abstract][Full Text] [Related]
18. Tumour necrosis factor-alpha (TNF-alpha) in patients who have asbestosis and develop cancer.
Partanen R; Koskinen H; Hemminki K
Occup Environ Med; 1995 May; 52(5):316-9. PubMed ID: 7795753
[TBL] [Abstract][Full Text] [Related]
19. Enhanced detection of early hepatocellular carcinoma by serum SELDI-TOF proteomic signature combined with alpha-fetoprotein marker.
Chen L; Ho DW; Lee NP; Sun S; Lam B; Wong KF; Yi X; Lau GK; Ng EW; Poon TC; Lai PB; Cai Z; Peng J; Leng X; Poon RT; Luk JM
Ann Surg Oncol; 2010 Sep; 17(9):2518-25. PubMed ID: 20354800
[TBL] [Abstract][Full Text] [Related]
20. New serum biomarkers for detection of tuberculosis using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
Liu JY; Jin L; Zhao MY; Zhang X; Liu CB; Zhang YX; Li FJ; Zhou JM; Wang HJ; Li JC
Clin Chem Lab Med; 2011 Oct; 49(10):1727-33. PubMed ID: 21671803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
